MARK CRANDALL: Open Payments
NPI 1841333531 · OWINGS MILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$237 in 14 payments from 5 companies in 2025. Trend: 2023 $139 · 2024 $633 · 2025 $237
Food & beverage: $237
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 5 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| ABBVIE INC. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
Products named: REXULTI, CAPLYTA, TRINTELLIX, VRAYLAR.
Industry payments across MD — which companies pay providers there.
